Bedair Dewidar

2.0k total citations · 2 hit papers
16 papers, 1.4k citations indexed

About

Bedair Dewidar is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Bedair Dewidar has authored 16 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Hepatology and 5 papers in Molecular Biology. Recurrent topics in Bedair Dewidar's work include Liver Disease Diagnosis and Treatment (7 papers), Liver physiology and pathology (5 papers) and Diet, Metabolism, and Disease (4 papers). Bedair Dewidar is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Liver physiology and pathology (5 papers) and Diet, Metabolism, and Disease (4 papers). Bedair Dewidar collaborates with scholars based in Germany, Egypt and Austria. Bedair Dewidar's co-authors include Steven Dooley, Christoph Meyer, Isabel Fabregat, Joaquim Moreno‐Càceres, Aranzazu Sánchez, Gianluigi Giannelli, Peter ten Dijke, Michael Roden, S. Kahl and Kalliopi Pafili and has published in prestigious journals such as PLoS ONE, Diabetes Care and Diabetes.

In The Last Decade

Bedair Dewidar

16 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019

2019 579 citations Bedair Dewidar, Christoph Meyer et al. Cells profile →
TGF‐β signalling and liver disease

2016 491 citations Isabel Fabregat, Joaquim Moreno‐Càceres et al. FEBS Journal profile →

Peers

Countries citing papers authored by Bedair Dewidar

Since Specialization

Citations

This map shows the geographic impact of Bedair Dewidar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bedair Dewidar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bedair Dewidar more than expected).

Fields of papers citing papers by Bedair Dewidar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bedair Dewidar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bedair Dewidar. The network helps show where Bedair Dewidar may publish in the future.

Co-authorship network of co-authors of Bedair Dewidar

This figure shows the co-authorship network connecting the top 25 collaborators of Bedair Dewidar. A scholar is included among the top collaborators of Bedair Dewidar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bedair Dewidar. Bedair Dewidar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Dysglycemia and liver lipid content determine the relationship of insulin resistance with hepatic OXPHOS capacity in obesity 2024 ·Journal of Hepatology ·S. Kahl, Klaus Straßburger, Giovanni Pacini, (unknown), Kalliopi Pafili, Lucia Mastrototaro, Bedair Dewidar, Theresia Sarabhai, Sandra Trenkamp, Iréne Esposito, Matthias Schlensak, Frank A. Granderath, Michael Roden	6
2	TGFβR1 inhibition drives hepatocellular carcinoma proliferation through induction of toll‐like‐receptor signalling 2024 ·International Journal of Experimental Pathology ·Fatma El Zahraa Ammar Mohamed, Bedair Dewidar, Tao Lin, Matthias Ebert, Steven Dooley, Nadja M. Meindl‐Beinker, Seddik Hammad	4
3	Alterations of hepatic energy metabolism in murine models of obesity, diabetes and fatty liver diseases 2023 ·EBioMedicine ·Bedair Dewidar, Lucia Mastrototaro, (unknown), Claudia Ress, Cesare Granata, (unknown), Dominik Pesta, (unknown), Martin Wolkersdorfer, Iréne Esposito, (unknown), (unknown), Aslihan Yavas, Michael Roden	28
4	Protection of pancreatic islets from oxidative cell death by a peripherally-active morphinan with increased drug safety 2023 ·Molecular Metabolism ·(unknown), (unknown), (unknown), Diran Herebıan, (unknown), Laura M. Levy, (unknown), (unknown), Haresh Ajani, (unknown), Torsten Hoffmann, (unknown), Anke Unger, Susanne Terheyden, (unknown), Bedair Dewidar, Michael Roden, Eckhard Lammert	1
5	Mitochondrial respiration is decreased in visceral but not subcutaneous adipose tissue in obese individuals with fatty liver disease 2022 ·Journal of Hepatology ·Kalliopi Pafili, S. Kahl, Lucia Mastrototaro, Klaus Straßburger, Dominik Pesta, Christian Herder, (unknown), Bedair Dewidar, (unknown), Cesare Granata, (unknown), Aslihan Yavas, Sofiya Gancheva, (unknown), Iréne Esposito, Matthias Schlensak, Michael Roden	31
6	Dietary lipid droplet structure in postnatal life improves hepatic energy and lipid metabolism in a mouse model for postnatal programming 2022 ·Pharmacological Research ·Tomáš Jeleník, Andrea Kodde, Dominik Pesta, Esther Phielix, Annemarie Oosting, (unknown), Bedair Dewidar, Lucia Mastrototaro, Sandra Trenkamp, Jaap Keijer, Eline M. van der Beek, Michael Roden	5
7	Impaired Hepatic Mitochondrial Capacity in Nonalcoholic Steatohepatitis Associated With Type 2 Diabetes 2022 ·Diabetes Care ·Sofiya Gancheva, S. Kahl, Dominik Pesta, Lucia Mastrototaro, Bedair Dewidar, Klaus Straßburger, (unknown), Iréne Esposito, Jürgen Weiß, Theresia Sarabhai, Martin Wolkersdorfer, Thomas Fleming, Peter P. Nawroth, Marcel Zimmermann, Andreas S. Reichert, Matthias Schlensak, Michael Roden	33
8	1212-P: Adipose Tissue Mitochondrial Function in Humans with Varying Liver Histology 2021 ·Diabetes ·Kalliopi Pafili, S. Kahl, Dominik Pesta, Klaus Straßburger, Lucia Mastrototaro, (unknown), Bedair Dewidar, Theresia Sarabhai, Iréne Esposito, Matthias Schlensak, Michael Roden	1
9	Expression of TLR-2 in hepatocellular carcinoma is associated with tumour proliferation, angiogenesis and Caspase-3 expression 2020 ·Pathology - Research and Practice ·Fatma El Zahraa Ammar Mohamed, Seddik Hammad, Tu Vinh Luong, Bedair Dewidar, Rajai Al-Jehani, Nathan Davies, Steven Dooley, Rajiv Jalan	12
10	Metabolic liver disease in diabetes – From mechanisms to clinical trials 2020 ·Metabolism ·Bedair Dewidar, S. Kahl, Kalliopi Pafili, Michael Roden	120
11	Human skin-derived ABCB5+ stem cell injection improves liver disease parameters in Mdr2KO mice 2019 ·Archives of Toxicology ·(unknown), Bedair Dewidar, Tao Lin, (unknown), Christoph Ganss, Mark A. Kluth, (unknown), (unknown), Bruno Christ, Markus H. Frank, Roger Vogelmann, Matthias Ebert, Steven Dooley	7
12	TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019 breakdown → 2019 ·Cells ·Bedair Dewidar, Christoph Meyer, Steven Dooley, (unknown)	579
13	Orphan nuclear receptor ERRγ is a key regulator of human fibrinogen gene expression 2017 ·PLoS ONE ·(unknown), Don‐Kyu Kim, Yan Lu, Yoon Seok Jung, (unknown), Younghoon Kim, Yong Soo Lee, Jina Kim, Bedair Dewidar, Won‐Il Jeong, In‐Kyu Lee, Sung Jin Cho, Steven Dooley, Chul‐Ho Lee, (unknown), Hueng‐Sik Choi	7
14	TGF‐β signalling and liver disease breakdown → 2016 ·FEBS Journal ·Isabel Fabregat, Joaquim Moreno‐Càceres, Aranzazu Sánchez, Steven Dooley, Bedair Dewidar, Gianluigi Giannelli, Peter ten Dijke	491
15	TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis: Updated 2015 ·Current Pathobiology Reports ·Bedair Dewidar, Jitka Soukupová, Isabel Fabregat, Steven Dooley	57
16	Histamine protects against the acute phase of experimentally-induced hepatic ischemia/re-perfusion 2012 ·Journal of Immunotoxicology ·(unknown), Alaa E. El‐Sisi, Bedair Dewidar, (unknown)	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact